Skybiotech Healthcare Limited Valuation
SKYBIOTECH · Consumer Discretionary · Current price ₹142.75
Is Skybiotech Healthcare Limited undervalued?
DocStoX estimates the fair value of Skybiotech Healthcare Limited at ₹182 per share, versus the current market price of ₹143. That puts the stock about +27.8% below our fair-value estimate, which we read as "Expensive". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 3 independent methods: Residual income (₹24), Relative P/E (₹535), Graham floor (₹118). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹24 (bear) to ₹182 (base) to ₹535 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
Valuation multiples
Skybiotech Healthcare Limited trades at a P/E of 13.4x and a P/B of 3.3x, with a dividend yield of 0.0%. Multiples are most useful compared against the company's own history and its sector peers — see the peer comparison for context.
Understand the ratios
More on Skybiotech Healthcare Limited
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.